Cargando…
Biomarker Discovery in Atherosclerotic Diseases Using Quantitative Nuclear Magnetic Resonance Metabolomics
Despite great progress in the management of atherosclerosis (AS), its subsequent cardiovascular disease (CVD) remains the leading cause of morbidity and mortality. This is probably due to insufficient risk detection using routine lipid testing; thus, there is a need for more effective approaches rel...
Autores principales: | Ma, Shuai, Xia, Mingfeng, Gao, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356911/ https://www.ncbi.nlm.nih.gov/pubmed/34395555 http://dx.doi.org/10.3389/fcvm.2021.681444 |
Ejemplares similares
-
Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2023) -
Applying multi-omics techniques to the discovery of biomarkers for acute aortic dissection
por: Hao, Xinyu, et al.
Publicado: (2022) -
Quantitative Assessment of Left and Right Atrial Strains Using Cardiovascular Magnetic Resonance Based Tissue Tracking
por: Qu, Yang-Yang, et al.
Publicado: (2021) -
Quantitative and qualitative features of carotid and coronary atherosclerotic plaque among men and women
por: Onnis, Carlotta, et al.
Publicado: (2022) -
Clinical features and metabolic reprogramming of atherosclerotic lesions in patients with chronic thromboembolic pulmonary hypertension
por: Liu, Jixiang, et al.
Publicado: (2022)